We’re pleased to announce Roger Pomerantz, MD, as Chairman of our Board of Directors. He will be a key asset as we work to assemble the first atlas of the #bioelectrome – the electrical networks by which cells communicate throughout the body. Read more: https://t.co/DJYuRCBVOS

Check out @GENbio's new piece, where our CEO discusses how understanding and manipulating bioelectric patterns could potentially allow us to rewrite them for the treatment of many conditions that are currently inadequately addressed by other modalities: https://t.co/h4o1mfdEqG

We are excited to welcome Jim Jenson, PhD as our #CEO! With more than 35 years of experience in the #biotech and #pharmaceutical industries, Jim joins our growing team as we build the first map of the druggable #bioelectrome. Read more here:

Morphoceuticals raises $8m to advance electroceutical approach to #regenerativemedicine Seed funding will advance programs using electroceuticals in limb regeneration and amputation stump health. @morphoceuticals @juvlabs #biotech #investment https://t.co/5pPIqvgCSE

Morphoceuticals is pleased to announce our seed funding for our programs using electroceuticals in limb regeneration and amputation stump health. https://t.co/lQnfYOIMFt

New paper @pai_vaibhav: https://t.co/hYiIufEEoy #bioelectric repair of eye, heart, and gut defects from a range of chemical teratogens and even from mutations of a key neurogenesis gene Notch! Molecular or drug (human-approved) methods repair defects in multiple germ layers. 🧵:

The new Morphoceuticals website has gone live! Go have a look at https://t.co/IrBcTxYmzc #regenerativemedicine #limbregeneration